| Vol. 5.38 – 2 November, 2020 |
| |
|
|
| The uptake of macrophage-derived glutamine by satellite cells through the glutamine transporter SLC1A5 activated mTOR and promoted the proliferation and differentiation of satellite cells. [Nature] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Scientists demonstrated that cardiac dysfunction and fatal outcomes caused by lethal scorpion envenomation in mice are mediated by a neuro-immune interaction linking IL-1 receptor signaling, prostaglandin E2 (PGE2), and acetylcholine release. [Nature Communications] |
|
|
|
| Researchers determined that growth differentiation factor 11 (GDF11) was abnormally downregulated in the heart tissue of myocardial infarction mice and hypoxic cardiomyocytes. [Cell Death & Disease] |
|
|
|
| The authors investigated the pathophysiological phenotypes and mechanisms using induced pluripotent stem cell (iPSC)-derived cardiomyocytes from two Brugada syndrome patients carrying a heterozygous SCN5A mutation p.S1812X. [Frontiers in Cell and Developmental Biology] |
|
|
|
| Researchers evaluated the effects of Ketoprofen in comparison with Diclofenac in immortalized human cardiomyocytes. The results obtained highlight the dose-dependent cardiotoxicity of Diclofenac compared to Ketoprofen. [Scientific Reports] |
|
|
|
| Scientists evaluated the effects of soluble factor interactions in indirect cocultures of dedifferentiated fat cells and induced pluripotent stem cell‐derived cardiomyocytes. [Cell Biology International] |
|
|
|
| The authors demonstrated ongoing cardiometabolic consequences by cross-fostering and following echocardiography, cardiomyocyte bioenergetics, mitochondria-mediated turnover and cell death following metabolic stress in aged adults. [iScience] |
|
|
|
| Using a comprehensive strategy that included cell-based approaches, animal models and human patients, scientists demonstrated that myocardial ischemia impairs the secretion of Cx43 into circulating, intracardiac and cardiomyocyte-derived vesicles. [Life Science Alliance] |
| |
|
|
| Researchers showed the inositol polyphosphate 5-phosphatase INPP5K regulates autophagic lysosome reformation, a lysosome recycling pathway, in muscle. INPP5K hydrolysed phosphatidylinositol-4,5-bisphosphate to phosphatidylinositol 4-phosphate and INPP5K mutations caused muscular dystrophy by unknown mechanisms. [Journal of Clinical Investigation] |
|
|
|
| Investigators revealed that dynamin-2 (Dyn2) was involved in postsynaptic development of neuromuscular junctions (NMJs). Mutations of Dyn2 have been linked to human muscular disorder and centronuclear myopathy, as well as featured with muscle atrophy and defective NMJs, yet the function of Dyn2 at the postsynaptic membrane is largely unknown. [Cell Reports] |
|
|
|
| Using a small animal radiation research platform, the authors investigated the effects of local fractionated radiation treatment on prepubertal satellite cells. [iScience] |
| |
|
|
| Investigators demonstrated that Msh homeobox 1 (Msx1) promotes the proliferation of myoblasts and mesenchymal stem cells by enhancing mitogen-activated protein kinase (MAPK) signaling. [Nucleic Acids Research] |
|
|
|
|
| The authors discuss the roles of microRNAs in the pathophysiological mechanisms of vascular calcification in smooth muscle cells and describes several interventions against vascular calcification by regulating microRNAs. [Journal of Cellular and Molecular Medicine] |
|
|
|
|
| Novus Therapeutics, Inc. announced that the first subject has been enrolled in the Phase IIa clinical trial evaluating AT-1501, the company’s lead product candidate, in adults with amyotrophic lateral sclerosis. [Novus Therapeutics, Inc.] |
|
|
|
|
| January 25 – January 27, 2021 Virtual |
|
|
|
|
|
| Center for Vascular and Inflammatory Diseases – Baltimore, Maryland, United States |
|
|
|
| Sanford Research – Sioux Falls, South Dakota, United States |
|
|
|
| Beth Israel Deaconess Medical Center – Boston, Massachusetts, United States |
|
|
|
| University of Luxembourg – Luxembourg, Luxembourg |
|
|
|
| University of Vermont – Burlington, Vermont, United States |
|
|
|
|